![]() |
市場調查報告書
商品編碼
1949487
雷射捕捉顯微切割市場 - 全球產業規模、佔有率、趨勢、機會及預測(按產品、系統類型、應用、最終用戶、地區和競爭格局分類,2021-2031年)Laser Capture Microdissection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By System Types, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球雷射捕獲晶粒市場預計將從 2025 年的 1.8546 億美元成長到 2031 年的 3.3161 億美元,複合年成長率達到 10.17%。
這項技術對於從組織樣本中分離特定細胞並進行詳細的分子分析至關重要,其發展得益於精準醫療的日益普及以及腫瘤學研究中對細胞學檢測的需求。慢性病盛行率的上升進一步推動了這一成長趨勢,因為它催生了對專業基因組分析工具的需求。例如,美國癌症協會估計,到2024年,美國新增癌症病例將首次超過200萬例,凸顯了解決複雜健康問題對精準研究設備的迫切需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 1.8546億美元 |
| 市場規模:2031年 | 3.3161億美元 |
| 複合年成長率:2026-2031年 | 10.17% |
| 成長最快的細分市場 | 軟體和服務 |
| 最大的市場 | 北美洲 |
市場擴張的一大障礙是這些系統的購買和維護成本高。高額的投資使得雷射捕獲晶粒技術主要局限於資金雄厚的製藥公司和研究機構,從而限制了預算有限的小規模實驗室採用該技術,並阻礙了這項先進技術在科學界的廣泛應用。
生命科學研發領域投資的不斷成長正成為全球雷射捕獲晶粒市場的主要推動力。各國政府和私人機構紛紛向基因組學研究投入大量資金,而基因組學研究則需要精準的樣本分離技術。例如,英國政府於2024年3月宣布投資3.6億英鎊,以加強生命科學領域的製造業,從而推動太空體學分析所需高成本技術的應用。這項需求也反映在10x Genomics公司的表現上,該公司2024年2月的營收達到6.187億美元。這一成長主要得益於空間生物學平台的廣泛應用,而這些平台通常需要組織晶粒樣本。
癌症和慢性疾病的日益增多進一步推動了雷射捕獲晶粒技術在揭示複雜疾病機制方面的應用。腫瘤學研究高度依賴這項技術將癌細胞與其周圍環境分離,以實現精準的生物標記發現。世界衛生組織(WHO)的預測也凸顯了此類精準工具的迫切性。 2024年2月,世衛組織預測,到2050年,新增癌症病例將超過3,500萬例。患者數量的激增促使製藥公司加快藥物研發進程,並推廣晶粒的應用,以確保用於關鍵基因組分析的生物樣本純度。
購置和維護雷射捕獲晶粒系統所需的大量資本投入是限制市場擴張的主要阻礙因素。這些儀器包含複雜的光學和雷射組件,導致初始成本高昂,實際上將資源有限的小規模學術實驗室和研究中心拒之門外。此外,持續的專業維護、專用耗材和技術培訓成本也會造成長期的財務負擔,阻礙預算緊張的機構採用這些系統。因此,基本客群主要集中在頂尖研究機構和製藥公司。
公共資金的波動進一步加劇了這一財務障礙,許多實驗室依賴公共資金購買設備。根據美國科學促進會(AAAS)2024年的預測,在最終聯邦預算中,美國國立衛生研究院(NIH)的撥款減少了0.8%,直接限制了可用於科學研究設備購置的資金。資源的縮減迫使各機構延後或取消高成本分析設備的採購。當實驗室面臨此類預算限制時,它們無法獲得昂貴儀器設備的津貼,這直接導致全球雷射捕獲晶粒市場成長速度放緩。
雷射捕獲晶粒與質譜聯用技術在深度可視化蛋白質組學領域的應用,透過將高解析度顯微鏡與深度分子分析相結合,正在重塑市場格局。這項先進的工作流程利用人工智慧驅動的影像分析來指導晶粒,使研究人員能夠分離特定的細胞表現型,進行超靈敏的下游質譜分析。與傳統的整體分析不同,該技術能夠在保留空間資訊的同時,對蛋白質組進行深度定量,這對於闡明腫瘤異質性等複雜的疾病機制至關重要。布魯克公司2025年3月發布的報告反映了此類整合解決方案的商業性成功,該報告預測,在太空生物學和蛋白質組學領域的業務擴張推動下,公司營收將超過33億美元。
同時,為滿足大規模臨床研究和生物銀行的需求,自動化高通量晶粒系統的研發正蓬勃發展。現代實驗室正逐步拋棄人工操作,轉而採用利用模式識別軟體快速、可重複地識別和切除目標細胞的自動化平台。這一趨勢的驅動力在於,需要對高維分析技術的樣品製備進行標準化,以確保數千個樣品的數據品質一致。 Standard Biotools截至2025年2月的財政年度財務表現也印證了這項生物工作流程產業化的趨勢。該公司公佈的年收入為1.751億美元,並強調了其在支持可擴展基因組應用工具方面的持續投入。
The Global Laser Capture Microdissection Market is projected to expand from USD 185.46 Million in 2025 to USD 331.61 Million by 2031, achieving a CAGR of 10.17%. This technology is essential for isolating specific cells from tissue samples to enable detailed molecular analysis, and its growth is being driven by a heightened focus on precision medicine and the necessity for cellular examination in oncology research. The rising prevalence of chronic diseases further supports this trajectory, as it creates a demand for specialized genomic profiling tools. For example, the American Cancer Society estimated in 2024 that new cancer cases in the United States would exceed 2 million for the first time, emphasizing the urgent need for precise research instruments to tackle complex health issues.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 185.46 Million |
| Market Size 2031 | USD 331.61 Million |
| CAGR 2026-2031 | 10.17% |
| Fastest Growing Segment | Software and Services |
| Largest Market | North America |
A significant barrier to market expansion is the substantial cost involved in purchasing and maintaining these systems. The high financial investment required limits the accessibility of laser capture microdissection technology primarily to well-funded pharmaceutical companies and research institutions. Consequently, adoption among smaller laboratories with tighter budgets is restricted, which hinders the broader reach and utilization of this advanced technology within the scientific community.
Market Driver
Increased investment in life science research and development acts as a major catalyst for the Global Laser Capture Microdissection Market, with governments and private entities channeling significant funds into genomic studies that require precise sample isolation. For instance, in March 2024, the UK Government announced a £360 million commitment to boost manufacturing in the life sciences sector, enabling laboratories to purchase high-cost technologies necessary for spatial omics. This demand is further evidenced by 10x Genomics, which reported revenue of $618.7 million in February 2024, driven by the strong adoption of spatial biology platforms that frequently rely on microdissected tissue inputs.
The growing prevalence of cancer and chronic diseases further compels the adoption of laser capture microdissection to elucidate complex disease mechanisms. Oncology research depends heavily on this technology to separate tumor cells from their surrounding environment, allowing for accurate biomarker discovery. The urgency for such precision tools is highlighted by global health projections; in February 2024, the World Health Organization predicted that new cancer cases would rise to over 35 million by 2050. This increasing patient burden drives pharmaceutical companies to accelerate drug discovery pipelines, thereby boosting the utilization of microdissection to ensure the purity of biological samples in critical genomic assays.
Market Challenge
The significant capital expenditure required to acquire and maintain laser capture microdissection systems serves as a primary restraint on market expansion. These instruments contain complex optical and laser components that result in high initial prices, effectively excluding smaller academic laboratories and research centers with limited funding. Furthermore, the recurring costs associated with specialized maintenance, proprietary consumables, and technical training create a long-term financial burden that discourages adoption among budget-constrained entities, leaving the customer base concentrated within elite research institutions and pharmaceutical companies.
This financial barrier is aggravated by fluctuations in public funding, which many laboratories depend on for capital equipment purchases. According to the American Association for the Advancement of Science in 2024, the finalized federal budget reduced funding for the National Institutes of Health by 0.8 percent, directly constraining the purchasing power available for research instrumentation. This contraction in resources forces institutions to delay or cancel the procurement of high-cost analytical tools. When laboratories face such fiscal tightening, the inability to secure grants for expensive machinery directly results in a slower growth rate for the global laser capture microdissection market.
Market Trends
The integration of laser capture microdissection with mass spectrometry for Deep Visual Proteomics is reshaping the market by bridging high-resolution microscopy with detailed molecular profiling. This advanced workflow uses artificial intelligence-driven image analysis to guide microdissection, enabling researchers to isolate specific cell phenotypes for ultra-sensitive downstream mass spectrometry. Unlike traditional bulk analysis, this approach preserves spatial context while allowing for deep quantification of the proteome, which is vital for understanding complex disease mechanisms such as tumor heterogeneity. The commercial success of such integrated solutions is reflected in Bruker Corporation's March 2025 report, which showed revenues exceeding $3.3 billion, partly attributed to its expansion in spatial biology and proteomics.
Simultaneously, the development of automated and high-throughput microdissection systems is gaining traction to meet the demands of large-scale clinical studies and biobanking. Modern laboratories are moving away from manual techniques in favor of automated platforms that leverage pattern recognition software to identify and excise target cells with high speed and reproducibility. This trend is driven by the need to standardize sample preparation for high-dimensional analysis technologies, ensuring consistent data quality across thousands of samples. This push toward industrialized biological workflows is evident in Standard BioTools' February 2025 financial results, where the company reported a full-year revenue of $175.1 million, underscoring the sustained investment in tools that support scalable genomic applications.
Report Scope
In this report, the Global Laser Capture Microdissection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Laser Capture Microdissection Market.
Global Laser Capture Microdissection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: